Skip to main content
. 2015 Jun 5;10(6):e0128208. doi: 10.1371/journal.pone.0128208

Fig 4. PK profiles of the developed nanoparticles vs. free drugs in rats (a) amlodipine, (b) hydrochlorothiazide, and (c) candesartan.

Fig 4